Company intelligence / Profile preview

Kaymogyn

Berlin-Pankow, Berlin, Germanydeumavan.com ↗

Ownership: Private
Development stage: Commercial

Overview

Kaymogyn GmbH develops and markets dermatologically tested, non-prescription medical ointments for intimate skin protection. Their flagship product, Deumavan Protective Ointment, is widely available in German pharmacies and has been used for over 20 years to alleviate symptoms related to intimate area discomfort[1][2][3].

Therapeutic areas: Dermatology
Modalities: Non-pharmacological therapyTopical ointment
Industry: Consumable Medical Devices

Drug pipeline

2 assets

Deumavan Protective Ointment

Commercial

Indications: Intimate skin conditions

1 more asset in the full pipeline.

Request access →

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed; open to expanding distributor network

Beyond the preview

Go deeper on Kaymogyn.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kaymogyn.

Explore the full profile